- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 08.04. | Docs sing praises of Madrigal's Rezdiffra, predict rapid uptake | ||
| 05.04. | In refiling $16.5B Catalent buyout pitch, Novo gives FTC more time for review | ||
| 05.04. | Bristol Myers' Abecma wins FDA nod in earlier multiple myeloma with updated boxed warning on secondary cancer | ||
| 05.04. | As Humira biosim sales languish, Boehringer Ingelheim plots layoffs in pivot to hybrid sales model | ||
| 05.04. | AstraZeneca's Imfinzi tackles another type of lung cancer with latest trial win | ||
| 05.04. | House committee to press FDA Commissioner Robert Califf on shortage oversight, other issues | ||
| 05.04. | AbbVie retains ad spending leadership, but some surprise drugs make the top 10 in March | ||
| 05.04. | Novartis finally ready for Pluvicto filing in earlier prostate cancer as patient survival data clear up | ||
| 04.04. | Sanofi pledges to keep polio vaccine supplies afloat in India after new approval | ||
| 04.04. | Bayer honors Trans Day of Visibility by highlighting work to protect LGBTQ+ workers | ||
| 04.04. | Pfizer's Velsipity poised to outpace BMS' Zeposia in ulcerative colitis market, but must head off further competition: analysts | ||
| 04.04. | Sanofi settles 4,000 Zantac state lawsuits, still faces Delaware claims | ||
| 04.04. | Arbutus, Genevant gain an edge in COVID patent scrap with Moderna | ||
| 04.04. | Teva, forging ahead with new strategy, inks biosimilar deal with Spain's mAbxience | ||
| 04.04. | Amylyx to pull failed ALS drug Relyvrio from market, cut 70% of staffers | ||
| 04.04. | Basilea completes marathon quest with FDA approval to treat 3 types of infections | ||
| 03.04. | Apotex acquires specialty drugmaker Searchlight in expansion move | ||
| 03.04. | Medicare price negotiations carry on as HHS responds to Big Pharma's IRA counteroffers | ||
| 03.04. | Vanda secures FDA approval for Fanapt to treat bipolar I, 15 years after schizophrenia nod | ||
| 03.04. | J&J doubles down on health equity with 100+ partnerships and renewed local health initiatives | ||
| 03.04. | Thermo Fisher plots layoffs at CA plasmid manufacturing site as demand swings | ||
| 03.04. | Novo Nordisk triumphs in UK probe of 'hyperbolic' Wegovy claims | ||
| 03.04. | Gilead finds new way to raise HIV awareness, locking in with dancer for voguing workshop | ||
| 02.04. | With deal to buy 7 Recipharm plants, private equity firm Blue Wolf plans new CDMO | ||
| 02.04. | KBI Biopharma taps pharma veteran to oversee quality and regulatory affairs |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
